nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—CYP2C18—Ifosfamide—testicular cancer	0.326	0.402	CbGbCtD
Clobazam—CYP2B6—Ifosfamide—testicular cancer	0.103	0.127	CbGbCtD
Clobazam—CYP2C19—Ifosfamide—testicular cancer	0.0655	0.0809	CbGbCtD
Clobazam—CYP2B6—Cisplatin—testicular cancer	0.0501	0.0619	CbGbCtD
Clobazam—ABCB1—Dactinomycin—testicular cancer	0.0447	0.0553	CbGbCtD
Clobazam—CYP2B6—Doxorubicin—testicular cancer	0.0336	0.0415	CbGbCtD
Clobazam—CYP3A4—Ifosfamide—testicular cancer	0.0317	0.0391	CbGbCtD
Clobazam—ABCB1—Vinblastine—testicular cancer	0.028	0.0346	CbGbCtD
Clobazam—ABCB1—Cisplatin—testicular cancer	0.0257	0.0317	CbGbCtD
Clobazam—ABCB1—Etoposide—testicular cancer	0.0252	0.0312	CbGbCtD
Clobazam—ABCB1—Doxorubicin—testicular cancer	0.0172	0.0213	CbGbCtD
Clobazam—CYP3A4—Vinblastine—testicular cancer	0.0168	0.0207	CbGbCtD
Clobazam—ABCB1—Methotrexate—testicular cancer	0.0167	0.0206	CbGbCtD
Clobazam—CYP3A4—Etoposide—testicular cancer	0.0151	0.0187	CbGbCtD
Clobazam—CYP3A4—Doxorubicin—testicular cancer	0.0103	0.0127	CbGbCtD
Clobazam—SLC6A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00309	0.202	CbGpPWpGaD
Clobazam—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00249	0.163	CbGpPWpGaD
Clobazam—SLC6A11—NRF2 pathway—SLC2A6—testicular cancer	0.00223	0.146	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—SLC2A6—testicular cancer	0.0018	0.117	CbGpPWpGaD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00141	0.0917	CbGpPWpGaD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00113	0.0739	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000715	0.0466	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000576	0.0376	CbGpPWpGaD
Clobazam—Vomiting—Vinblastine—testicular cancer	0.000411	0.00235	CcSEcCtD
Clobazam—Decreased appetite—Ifosfamide—testicular cancer	0.000406	0.00232	CcSEcCtD
Clobazam—Headache—Vinblastine—testicular cancer	0.000405	0.00231	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000405	0.00231	CcSEcCtD
Clobazam—Leukopenia—Etoposide—testicular cancer	0.000405	0.00231	CcSEcCtD
Clobazam—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000403	0.0023	CcSEcCtD
Clobazam—Body temperature increased—Dactinomycin—testicular cancer	0.000403	0.0023	CcSEcCtD
Clobazam—Fatigue—Ifosfamide—testicular cancer	0.000403	0.0023	CcSEcCtD
Clobazam—Infection—Cisplatin—testicular cancer	0.0004	0.00228	CcSEcCtD
Clobazam—Constipation—Ifosfamide—testicular cancer	0.000399	0.00228	CcSEcCtD
Clobazam—Lethargy—Doxorubicin—testicular cancer	0.000397	0.00227	CcSEcCtD
Clobazam—Ataxia—Epirubicin—testicular cancer	0.000396	0.00226	CcSEcCtD
Clobazam—Nervous system disorder—Cisplatin—testicular cancer	0.000395	0.00225	CcSEcCtD
Clobazam—Cough—Etoposide—testicular cancer	0.000394	0.00225	CcSEcCtD
Clobazam—Thrombocytopenia—Cisplatin—testicular cancer	0.000394	0.00225	CcSEcCtD
Clobazam—Asthenia—Bleomycin—testicular cancer	0.000392	0.00224	CcSEcCtD
Clobazam—Skin disorder—Cisplatin—testicular cancer	0.000391	0.00223	CcSEcCtD
Clobazam—Diplopia—Doxorubicin—testicular cancer	0.000389	0.00222	CcSEcCtD
Clobazam—Osteoarthritis—Doxorubicin—testicular cancer	0.000389	0.00222	CcSEcCtD
Clobazam—Hyperhidrosis—Cisplatin—testicular cancer	0.000389	0.00222	CcSEcCtD
Clobazam—Asthma—Methotrexate—testicular cancer	0.000389	0.00222	CcSEcCtD
Clobazam—Liver function test abnormal—Epirubicin—testicular cancer	0.000388	0.00222	CcSEcCtD
Clobazam—Pruritus—Bleomycin—testicular cancer	0.000387	0.0022	CcSEcCtD
Clobazam—Feeling abnormal—Ifosfamide—testicular cancer	0.000385	0.00219	CcSEcCtD
Clobazam—Eosinophilia—Methotrexate—testicular cancer	0.000385	0.00219	CcSEcCtD
Clobazam—Nausea—Vinblastine—testicular cancer	0.000384	0.00219	CcSEcCtD
Clobazam—Anorexia—Cisplatin—testicular cancer	0.000384	0.00219	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000382	0.00218	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000379	0.00216	CcSEcCtD
Clobazam—Hypotension—Cisplatin—testicular cancer	0.000376	0.00215	CcSEcCtD
Clobazam—Confusional state—Etoposide—testicular cancer	0.000372	0.00212	CcSEcCtD
Clobazam—Muscular weakness—Epirubicin—testicular cancer	0.000371	0.00212	CcSEcCtD
Clobazam—Urticaria—Ifosfamide—testicular cancer	0.000371	0.00212	CcSEcCtD
Clobazam—Body temperature increased—Ifosfamide—testicular cancer	0.000369	0.00211	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000367	0.00209	CcSEcCtD
Clobazam—Infection—Etoposide—testicular cancer	0.000366	0.00209	CcSEcCtD
Clobazam—Abdominal distension—Epirubicin—testicular cancer	0.000366	0.00209	CcSEcCtD
Clobazam—Ataxia—Doxorubicin—testicular cancer	0.000366	0.00209	CcSEcCtD
Clobazam—Asthenia—Dactinomycin—testicular cancer	0.000366	0.00209	CcSEcCtD
Clobazam—Dysphagia—Epirubicin—testicular cancer	0.000364	0.00207	CcSEcCtD
Clobazam—Asthma—Epirubicin—testicular cancer	0.000364	0.00207	CcSEcCtD
Clobazam—Thrombocytopenia—Etoposide—testicular cancer	0.000361	0.00206	CcSEcCtD
Clobazam—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000361	0.00206	CcSEcCtD
Clobazam—Eosinophilia—Epirubicin—testicular cancer	0.00036	0.00205	CcSEcCtD
Clobazam—Liver function test abnormal—Doxorubicin—testicular cancer	0.000359	0.00205	CcSEcCtD
Clobazam—Skin disorder—Etoposide—testicular cancer	0.000358	0.00204	CcSEcCtD
Clobazam—Hyperhidrosis—Etoposide—testicular cancer	0.000357	0.00203	CcSEcCtD
Clobazam—Anorexia—Etoposide—testicular cancer	0.000352	0.00201	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000351	0.002	CcSEcCtD
Clobazam—Decreased appetite—Cisplatin—testicular cancer	0.00035	0.002	CcSEcCtD
Clobazam—Bronchitis—Epirubicin—testicular cancer	0.00035	0.00199	CcSEcCtD
Clobazam—Diarrhoea—Dactinomycin—testicular cancer	0.000349	0.00199	CcSEcCtD
Clobazam—Pneumonia—Methotrexate—testicular cancer	0.000348	0.00199	CcSEcCtD
Clobazam—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000348	0.00198	CcSEcCtD
Clobazam—Vomiting—Bleomycin—testicular cancer	0.000347	0.00198	CcSEcCtD
Clobazam—Drowsiness—Methotrexate—testicular cancer	0.000346	0.00198	CcSEcCtD
Clobazam—Infestation NOS—Methotrexate—testicular cancer	0.000346	0.00198	CcSEcCtD
Clobazam—Infestation—Methotrexate—testicular cancer	0.000346	0.00198	CcSEcCtD
Clobazam—Depression—Methotrexate—testicular cancer	0.000345	0.00197	CcSEcCtD
Clobazam—Hypotension—Etoposide—testicular cancer	0.000345	0.00197	CcSEcCtD
Clobazam—Rash—Bleomycin—testicular cancer	0.000345	0.00197	CcSEcCtD
Clobazam—Dermatitis—Bleomycin—testicular cancer	0.000344	0.00196	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000343	0.00196	CcSEcCtD
Clobazam—Muscular weakness—Doxorubicin—testicular cancer	0.000343	0.00196	CcSEcCtD
Clobazam—Abdominal distension—Doxorubicin—testicular cancer	0.000339	0.00193	CcSEcCtD
Clobazam—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000338	0.00193	CcSEcCtD
Clobazam—Asthma—Doxorubicin—testicular cancer	0.000336	0.00192	CcSEcCtD
Clobazam—Dysphagia—Doxorubicin—testicular cancer	0.000336	0.00192	CcSEcCtD
Clobazam—Asthenia—Ifosfamide—testicular cancer	0.000335	0.00191	CcSEcCtD
Clobazam—Eosinophilia—Doxorubicin—testicular cancer	0.000333	0.0019	CcSEcCtD
Clobazam—Sweating—Methotrexate—testicular cancer	0.000332	0.00189	CcSEcCtD
Clobazam—Feeling abnormal—Cisplatin—testicular cancer	0.000332	0.00189	CcSEcCtD
Clobazam—Weight increased—Epirubicin—testicular cancer	0.000331	0.00189	CcSEcCtD
Clobazam—Pruritus—Ifosfamide—testicular cancer	0.00033	0.00188	CcSEcCtD
Clobazam—Somnolence—Etoposide—testicular cancer	0.000328	0.00187	CcSEcCtD
Clobazam—Pneumonia—Epirubicin—testicular cancer	0.000326	0.00186	CcSEcCtD
Clobazam—Nausea—Bleomycin—testicular cancer	0.000325	0.00185	CcSEcCtD
Clobazam—Infestation NOS—Epirubicin—testicular cancer	0.000324	0.00185	CcSEcCtD
Clobazam—Drowsiness—Epirubicin—testicular cancer	0.000324	0.00185	CcSEcCtD
Clobazam—Infestation—Epirubicin—testicular cancer	0.000324	0.00185	CcSEcCtD
Clobazam—Vomiting—Dactinomycin—testicular cancer	0.000324	0.00185	CcSEcCtD
Clobazam—Bronchitis—Doxorubicin—testicular cancer	0.000324	0.00185	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000321	0.00183	CcSEcCtD
Clobazam—Rash—Dactinomycin—testicular cancer	0.000321	0.00183	CcSEcCtD
Clobazam—Decreased appetite—Etoposide—testicular cancer	0.000321	0.00183	CcSEcCtD
Clobazam—Diarrhoea—Ifosfamide—testicular cancer	0.00032	0.00182	CcSEcCtD
Clobazam—Gastrointestinal disorder—Etoposide—testicular cancer	0.000318	0.00182	CcSEcCtD
Clobazam—Body temperature increased—Cisplatin—testicular cancer	0.000318	0.00182	CcSEcCtD
Clobazam—Fatigue—Etoposide—testicular cancer	0.000318	0.00181	CcSEcCtD
Clobazam—Constipation—Etoposide—testicular cancer	0.000315	0.0018	CcSEcCtD
Clobazam—Urinary tract infection—Epirubicin—testicular cancer	0.000315	0.0018	CcSEcCtD
Clobazam—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000313	0.00178	CcSEcCtD
Clobazam—Sweating—Epirubicin—testicular cancer	0.000311	0.00177	CcSEcCtD
Clobazam—Dizziness—Ifosfamide—testicular cancer	0.000309	0.00176	CcSEcCtD
Clobazam—Weight increased—Doxorubicin—testicular cancer	0.000306	0.00175	CcSEcCtD
Clobazam—Feeling abnormal—Etoposide—testicular cancer	0.000304	0.00173	CcSEcCtD
Clobazam—Nausea—Dactinomycin—testicular cancer	0.000303	0.00173	CcSEcCtD
Clobazam—Pneumonia—Doxorubicin—testicular cancer	0.000302	0.00172	CcSEcCtD
Clobazam—Drowsiness—Doxorubicin—testicular cancer	0.0003	0.00171	CcSEcCtD
Clobazam—Infestation—Doxorubicin—testicular cancer	0.0003	0.00171	CcSEcCtD
Clobazam—Infestation NOS—Doxorubicin—testicular cancer	0.0003	0.00171	CcSEcCtD
Clobazam—Visual impairment—Methotrexate—testicular cancer	0.0003	0.00171	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000297	0.0017	CcSEcCtD
Clobazam—Vomiting—Ifosfamide—testicular cancer	0.000297	0.00169	CcSEcCtD
Clobazam—Rash—Ifosfamide—testicular cancer	0.000294	0.00168	CcSEcCtD
Clobazam—Dermatitis—Ifosfamide—testicular cancer	0.000294	0.00168	CcSEcCtD
Clobazam—Erythema multiforme—Methotrexate—testicular cancer	0.000294	0.00168	CcSEcCtD
Clobazam—Urticaria—Etoposide—testicular cancer	0.000293	0.00167	CcSEcCtD
Clobazam—Body temperature increased—Etoposide—testicular cancer	0.000292	0.00166	CcSEcCtD
Clobazam—Urinary tract infection—Doxorubicin—testicular cancer	0.000292	0.00166	CcSEcCtD
Clobazam—Eye disorder—Methotrexate—testicular cancer	0.000291	0.00166	CcSEcCtD
Clobazam—Asthenia—Cisplatin—testicular cancer	0.000289	0.00165	CcSEcCtD
Clobazam—Sweating—Doxorubicin—testicular cancer	0.000288	0.00164	CcSEcCtD
Clobazam—Visual impairment—Epirubicin—testicular cancer	0.00028	0.0016	CcSEcCtD
Clobazam—Nausea—Ifosfamide—testicular cancer	0.000277	0.00158	CcSEcCtD
Clobazam—Diarrhoea—Cisplatin—testicular cancer	0.000275	0.00157	CcSEcCtD
Clobazam—Erythema multiforme—Epirubicin—testicular cancer	0.000275	0.00157	CcSEcCtD
Clobazam—Mental disorder—Methotrexate—testicular cancer	0.000272	0.00155	CcSEcCtD
Clobazam—Eye disorder—Epirubicin—testicular cancer	0.000272	0.00155	CcSEcCtD
Clobazam—Malnutrition—Methotrexate—testicular cancer	0.000271	0.00154	CcSEcCtD
Clobazam—Asthenia—Etoposide—testicular cancer	0.000265	0.00151	CcSEcCtD
Clobazam—Pruritus—Etoposide—testicular cancer	0.000261	0.00149	CcSEcCtD
Clobazam—Visual impairment—Doxorubicin—testicular cancer	0.000259	0.00148	CcSEcCtD
Clobazam—Vomiting—Cisplatin—testicular cancer	0.000256	0.00146	CcSEcCtD
Clobazam—Vision blurred—Methotrexate—testicular cancer	0.000255	0.00146	CcSEcCtD
Clobazam—Mental disorder—Epirubicin—testicular cancer	0.000255	0.00145	CcSEcCtD
Clobazam—Erythema multiforme—Doxorubicin—testicular cancer	0.000255	0.00145	CcSEcCtD
Clobazam—Rash—Cisplatin—testicular cancer	0.000254	0.00145	CcSEcCtD
Clobazam—Dermatitis—Cisplatin—testicular cancer	0.000254	0.00145	CcSEcCtD
Clobazam—Malnutrition—Epirubicin—testicular cancer	0.000253	0.00144	CcSEcCtD
Clobazam—Diarrhoea—Etoposide—testicular cancer	0.000252	0.00144	CcSEcCtD
Clobazam—Eye disorder—Doxorubicin—testicular cancer	0.000252	0.00144	CcSEcCtD
Clobazam—Anaemia—Methotrexate—testicular cancer	0.00025	0.00143	CcSEcCtD
Clobazam—Tension—Epirubicin—testicular cancer	0.000249	0.00142	CcSEcCtD
Clobazam—Nervousness—Epirubicin—testicular cancer	0.000246	0.0014	CcSEcCtD
Clobazam—Dizziness—Etoposide—testicular cancer	0.000244	0.00139	CcSEcCtD
Clobazam—Muscle spasms—Epirubicin—testicular cancer	0.000244	0.00139	CcSEcCtD
Clobazam—Leukopenia—Methotrexate—testicular cancer	0.000242	0.00138	CcSEcCtD
Clobazam—Nausea—Cisplatin—testicular cancer	0.000239	0.00136	CcSEcCtD
Clobazam—Vision blurred—Epirubicin—testicular cancer	0.000239	0.00136	CcSEcCtD
Clobazam—Cough—Methotrexate—testicular cancer	0.000236	0.00135	CcSEcCtD
Clobazam—Mental disorder—Doxorubicin—testicular cancer	0.000236	0.00135	CcSEcCtD
Clobazam—Vomiting—Etoposide—testicular cancer	0.000235	0.00134	CcSEcCtD
Clobazam—Malnutrition—Doxorubicin—testicular cancer	0.000234	0.00134	CcSEcCtD
Clobazam—Anaemia—Epirubicin—testicular cancer	0.000234	0.00134	CcSEcCtD
Clobazam—Agitation—Epirubicin—testicular cancer	0.000233	0.00133	CcSEcCtD
Clobazam—Rash—Etoposide—testicular cancer	0.000233	0.00133	CcSEcCtD
Clobazam—Dermatitis—Etoposide—testicular cancer	0.000232	0.00133	CcSEcCtD
Clobazam—Headache—Etoposide—testicular cancer	0.000231	0.00132	CcSEcCtD
Clobazam—Myalgia—Methotrexate—testicular cancer	0.00023	0.00131	CcSEcCtD
Clobazam—Tension—Doxorubicin—testicular cancer	0.00023	0.00131	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000229	0.00131	CcSEcCtD
Clobazam—Nervousness—Doxorubicin—testicular cancer	0.000228	0.0013	CcSEcCtD
Clobazam—Leukopenia—Epirubicin—testicular cancer	0.000227	0.00129	CcSEcCtD
Clobazam—Muscle spasms—Doxorubicin—testicular cancer	0.000225	0.00129	CcSEcCtD
Clobazam—Confusional state—Methotrexate—testicular cancer	0.000223	0.00127	CcSEcCtD
Clobazam—Cough—Epirubicin—testicular cancer	0.000221	0.00126	CcSEcCtD
Clobazam—Vision blurred—Doxorubicin—testicular cancer	0.000221	0.00126	CcSEcCtD
Clobazam—Infection—Methotrexate—testicular cancer	0.000219	0.00125	CcSEcCtD
Clobazam—Nausea—Etoposide—testicular cancer	0.000219	0.00125	CcSEcCtD
Clobazam—Nervous system disorder—Methotrexate—testicular cancer	0.000217	0.00124	CcSEcCtD
Clobazam—Anaemia—Doxorubicin—testicular cancer	0.000217	0.00124	CcSEcCtD
Clobazam—Thrombocytopenia—Methotrexate—testicular cancer	0.000216	0.00123	CcSEcCtD
Clobazam—Myalgia—Epirubicin—testicular cancer	0.000216	0.00123	CcSEcCtD
Clobazam—Agitation—Doxorubicin—testicular cancer	0.000215	0.00123	CcSEcCtD
Clobazam—Anxiety—Epirubicin—testicular cancer	0.000215	0.00123	CcSEcCtD
Clobazam—Skin disorder—Methotrexate—testicular cancer	0.000215	0.00122	CcSEcCtD
Clobazam—CYP2C18—Biological oxidations—HPGDS—testicular cancer	0.000214	0.014	CbGpPWpGaD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000214	0.00122	CcSEcCtD
Clobazam—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000214	0.014	CbGpPWpGaD
Clobazam—Hyperhidrosis—Methotrexate—testicular cancer	0.000214	0.00122	CcSEcCtD
Clobazam—Dry mouth—Epirubicin—testicular cancer	0.000211	0.0012	CcSEcCtD
Clobazam—Anorexia—Methotrexate—testicular cancer	0.000211	0.0012	CcSEcCtD
Clobazam—Leukopenia—Doxorubicin—testicular cancer	0.00021	0.0012	CcSEcCtD
Clobazam—Confusional state—Epirubicin—testicular cancer	0.000208	0.00119	CcSEcCtD
Clobazam—Hypotension—Methotrexate—testicular cancer	0.000206	0.00118	CcSEcCtD
Clobazam—Infection—Epirubicin—testicular cancer	0.000205	0.00117	CcSEcCtD
Clobazam—Cough—Doxorubicin—testicular cancer	0.000205	0.00117	CcSEcCtD
Clobazam—Nervous system disorder—Epirubicin—testicular cancer	0.000203	0.00116	CcSEcCtD
Clobazam—Thrombocytopenia—Epirubicin—testicular cancer	0.000202	0.00115	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000201	0.00115	CcSEcCtD
Clobazam—Skin disorder—Epirubicin—testicular cancer	0.000201	0.00115	CcSEcCtD
Clobazam—Hyperhidrosis—Epirubicin—testicular cancer	0.0002	0.00114	CcSEcCtD
Clobazam—Insomnia—Methotrexate—testicular cancer	0.0002	0.00114	CcSEcCtD
Clobazam—Myalgia—Doxorubicin—testicular cancer	0.0002	0.00114	CcSEcCtD
Clobazam—Anxiety—Doxorubicin—testicular cancer	0.000199	0.00113	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000198	0.00113	CcSEcCtD
Clobazam—Anorexia—Epirubicin—testicular cancer	0.000197	0.00112	CcSEcCtD
Clobazam—Somnolence—Methotrexate—testicular cancer	0.000196	0.00112	CcSEcCtD
Clobazam—Dry mouth—Doxorubicin—testicular cancer	0.000195	0.00111	CcSEcCtD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000195	0.0127	CbGpPWpGaD
Clobazam—Hypotension—Epirubicin—testicular cancer	0.000193	0.0011	CcSEcCtD
Clobazam—Confusional state—Doxorubicin—testicular cancer	0.000193	0.0011	CcSEcCtD
Clobazam—Decreased appetite—Methotrexate—testicular cancer	0.000192	0.0011	CcSEcCtD
Clobazam—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000191	0.00109	CcSEcCtD
Clobazam—Fatigue—Methotrexate—testicular cancer	0.00019	0.00109	CcSEcCtD
Clobazam—Infection—Doxorubicin—testicular cancer	0.00019	0.00108	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000188	0.00107	CcSEcCtD
Clobazam—Nervous system disorder—Doxorubicin—testicular cancer	0.000188	0.00107	CcSEcCtD
Clobazam—Thrombocytopenia—Doxorubicin—testicular cancer	0.000187	0.00107	CcSEcCtD
Clobazam—Insomnia—Epirubicin—testicular cancer	0.000187	0.00107	CcSEcCtD
Clobazam—Skin disorder—Doxorubicin—testicular cancer	0.000186	0.00106	CcSEcCtD
Clobazam—Hyperhidrosis—Doxorubicin—testicular cancer	0.000185	0.00105	CcSEcCtD
Clobazam—Somnolence—Epirubicin—testicular cancer	0.000184	0.00105	CcSEcCtD
Clobazam—Anorexia—Doxorubicin—testicular cancer	0.000182	0.00104	CcSEcCtD
Clobazam—Feeling abnormal—Methotrexate—testicular cancer	0.000182	0.00104	CcSEcCtD
Clobazam—Decreased appetite—Epirubicin—testicular cancer	0.00018	0.00103	CcSEcCtD
Clobazam—Hypotension—Doxorubicin—testicular cancer	0.000179	0.00102	CcSEcCtD
Clobazam—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000178	0.00102	CcSEcCtD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000178	0.0116	CbGpPWpGaD
Clobazam—Fatigue—Epirubicin—testicular cancer	0.000178	0.00102	CcSEcCtD
Clobazam—Constipation—Epirubicin—testicular cancer	0.000177	0.00101	CcSEcCtD
Clobazam—Urticaria—Methotrexate—testicular cancer	0.000176	0.001	CcSEcCtD
Clobazam—Body temperature increased—Methotrexate—testicular cancer	0.000175	0.000996	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000174	0.000994	CcSEcCtD
Clobazam—Insomnia—Doxorubicin—testicular cancer	0.000173	0.000987	CcSEcCtD
Clobazam—Feeling abnormal—Epirubicin—testicular cancer	0.00017	0.000972	CcSEcCtD
Clobazam—Somnolence—Doxorubicin—testicular cancer	0.00017	0.00097	CcSEcCtD
Clobazam—Decreased appetite—Doxorubicin—testicular cancer	0.000166	0.000948	CcSEcCtD
Clobazam—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000165	0.000942	CcSEcCtD
Clobazam—Fatigue—Doxorubicin—testicular cancer	0.000165	0.000941	CcSEcCtD
Clobazam—Urticaria—Epirubicin—testicular cancer	0.000164	0.000937	CcSEcCtD
Clobazam—Constipation—Doxorubicin—testicular cancer	0.000164	0.000933	CcSEcCtD
Clobazam—Body temperature increased—Epirubicin—testicular cancer	0.000163	0.000932	CcSEcCtD
Clobazam—Asthenia—Methotrexate—testicular cancer	0.000159	0.000904	CcSEcCtD
Clobazam—Feeling abnormal—Doxorubicin—testicular cancer	0.000158	0.000899	CcSEcCtD
Clobazam—Pruritus—Methotrexate—testicular cancer	0.000156	0.000891	CcSEcCtD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000156	0.0102	CbGpPWpGaD
Clobazam—Urticaria—Doxorubicin—testicular cancer	0.000152	0.000867	CcSEcCtD
Clobazam—Body temperature increased—Doxorubicin—testicular cancer	0.000151	0.000863	CcSEcCtD
Clobazam—Diarrhoea—Methotrexate—testicular cancer	0.000151	0.000862	CcSEcCtD
Clobazam—Asthenia—Epirubicin—testicular cancer	0.000148	0.000846	CcSEcCtD
Clobazam—Pruritus—Epirubicin—testicular cancer	0.000146	0.000834	CcSEcCtD
Clobazam—Dizziness—Methotrexate—testicular cancer	0.000146	0.000833	CcSEcCtD
Clobazam—Diarrhoea—Epirubicin—testicular cancer	0.000141	0.000807	CcSEcCtD
Clobazam—Vomiting—Methotrexate—testicular cancer	0.00014	0.000801	CcSEcCtD
Clobazam—Rash—Methotrexate—testicular cancer	0.000139	0.000794	CcSEcCtD
Clobazam—Dermatitis—Methotrexate—testicular cancer	0.000139	0.000794	CcSEcCtD
Clobazam—Headache—Methotrexate—testicular cancer	0.000138	0.000789	CcSEcCtD
Clobazam—Asthenia—Doxorubicin—testicular cancer	0.000137	0.000783	CcSEcCtD
Clobazam—Dizziness—Epirubicin—testicular cancer	0.000137	0.00078	CcSEcCtD
Clobazam—Pruritus—Doxorubicin—testicular cancer	0.000135	0.000772	CcSEcCtD
Clobazam—Vomiting—Epirubicin—testicular cancer	0.000131	0.00075	CcSEcCtD
Clobazam—Nausea—Methotrexate—testicular cancer	0.000131	0.000748	CcSEcCtD
Clobazam—Diarrhoea—Doxorubicin—testicular cancer	0.000131	0.000747	CcSEcCtD
Clobazam—Rash—Epirubicin—testicular cancer	0.00013	0.000744	CcSEcCtD
Clobazam—Dermatitis—Epirubicin—testicular cancer	0.00013	0.000743	CcSEcCtD
Clobazam—Headache—Epirubicin—testicular cancer	0.00013	0.000739	CcSEcCtD
Clobazam—Dizziness—Doxorubicin—testicular cancer	0.000127	0.000722	CcSEcCtD
Clobazam—Nausea—Epirubicin—testicular cancer	0.000123	0.0007	CcSEcCtD
Clobazam—Vomiting—Doxorubicin—testicular cancer	0.000122	0.000694	CcSEcCtD
Clobazam—SLC6A11—Metabolism—HPGDS—testicular cancer	0.000121	0.00792	CbGpPWpGaD
Clobazam—Rash—Doxorubicin—testicular cancer	0.000121	0.000688	CcSEcCtD
Clobazam—Dermatitis—Doxorubicin—testicular cancer	0.000121	0.000687	CcSEcCtD
Clobazam—Headache—Doxorubicin—testicular cancer	0.00012	0.000684	CcSEcCtD
Clobazam—Nausea—Doxorubicin—testicular cancer	0.000114	0.000648	CcSEcCtD
Clobazam—CYP2B6—Biological oxidations—HPGDS—testicular cancer	0.000105	0.00687	CbGpPWpGaD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	9.74e-05	0.00635	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—STK11—testicular cancer	8.83e-05	0.00576	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—HPGDS—testicular cancer	7.96e-05	0.00519	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	7.82e-05	0.0051	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	7.15e-05	0.00466	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	5.19e-05	0.00339	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—HPGDS—testicular cancer	4.79e-05	0.00312	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—HPGDS—testicular cancer	3.67e-05	0.00239	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.06e-05	0.00199	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—STK11—testicular cancer	2.66e-05	0.00174	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—HPGDS—testicular cancer	1.8e-05	0.00118	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—HPGDS—testicular cancer	1.36e-05	0.000888	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—HPGDS—testicular cancer	1.33e-05	0.000867	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—STK11—testicular cancer	1.31e-05	0.000854	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—STK11—testicular cancer	9.89e-06	0.000645	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—STK11—testicular cancer	9.66e-06	0.00063	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—HPGDS—testicular cancer	8.19e-06	0.000534	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—STK11—testicular cancer	5.95e-06	0.000388	CbGpPWpGaD
